Treace Net Interest Income from 2010 to 2026
| TMCI Stock | USD 2.32 0.02 0.87% |
Net Interest Income | First Reported 2020-03-31 | Previous Quarter -546 K | Current Value -704 K | Quarterly Volatility 691.7 K |
Check Treace Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Treace Medical's main balance sheet or income statement drivers, such as Interest Income of 5.9 M, Depreciation And Amortization of 10.2 M or Interest Expense of 4.4 M, as well as many indicators such as Price To Sales Ratio of 2.41, Dividend Yield of 0.0 or PTB Ratio of 4.47. Treace financial statements analysis is a perfect complement when working with Treace Medical Valuation or Volatility modules.
Treace | Net Interest Income | Build AI portfolio with Treace Stock |
The Net Interest Income trend for Treace Medical Concepts offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Treace Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Treace Medical's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Treace Medical Concepts over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Treace Medical's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Treace Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Treace Net Interest Income Regression Statistics
| Arithmetic Mean | (1,201,911) | |
| Geometric Mean | 827,481 | |
| Coefficient Of Variation | (114.52) | |
| Mean Deviation | 993,796 | |
| Median | (730,000) | |
| Standard Deviation | 1,376,424 | |
| Sample Variance | 1.9T | |
| Range | 4.7M | |
| R-Value | (0.16) | |
| Mean Square Error | 2T | |
| R-Squared | 0.03 | |
| Significance | 0.54 | |
| Slope | (43,125) | |
| Total Sum of Squares | 30.3T |
Treace Net Interest Income History
About Treace Medical Financial Statements
Investors use fundamental indicators, such as Treace Medical's Net Interest Income, to determine how well the company is positioned to perform in the future. Although Treace Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -435.9 K | -457.6 K |
Currently Active Assets on Macroaxis
When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:Check out the analysis of Treace Medical Correlation against competitors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is there potential for Health Care Equipment & Supplies market expansion? Will Treace introduce new products? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share | Quarterly Revenue Growth 0.114 | Return On Assets | Return On Equity |
Understanding Treace Medical Concepts requires distinguishing between market price and book value, where the latter reflects Treace's accounting equity. The concept of intrinsic value—what Treace Medical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Treace Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Treace Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.